The formation of Gain’s new Clinical Advisory Board marks a significant strategic step forward for Gain, as GT-02287 advances into Parkinson’s disease patients,” stated Gene Mack, CEO of Gain ...
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today ...
Initially declared to be in stable condition pending additional evaluation, DuBose remained at a Houston hospital days after the team's Week 15 game. Dolphins head coach Mike McDaniel told ...